Our study suggests that AKR1C3 might share the same properties as antioxidant enzymes in alleviation of ROS accumulation in tumor cells and may serve as a potential biomarker for predicting prognosis of radiotherapy and even direct a targeted therapy for esophageal cancer and other tumors. The gene discussed is AKR1C3; the disease is esophageal cancer.